文献速递泌尿生殖腹部MR

基于双参数MRI的定量影像组学模型用于前列腺癌术后组织病理学与生化复发的无创预测:多中心研究

Bi-parametric MRI-based quantification radiomics model for the noninvasive prediction of histopathology and biochemical recurrence after prostate cancer surgery: a multicenter study.
PubMed 文献 · Abdom Radiol (NY) · 2025-03-17

该多中心回顾性研究基于666例前列腺癌患者的术前双参数MRI及临床病理数据,构建影像组学模型预测生化复发、包膜外侵犯、盆腔淋巴结转移及Gleason分级分组,并将影像组学与临床病理变量联合建模预测生化复发;不依赖病理活检的联合模型M3在测试队列中AUC为0.884,表现最佳。

要点

  • 联合模型M3不依赖病理活检,测试队列预测BCR的AUC为0.884,优于M1和M2。
  • pred-PLNM模型AUC为0.896,pred-ECE为0.764,pred-BCR为0.841,pred-GG为0.698。
  • M3与M1、M2的AUC差异有统计学意义(p=0.028;p=0.044)。

核心结论

  • 本研究构建的不依赖病理活检的联合模型可无创预测前列腺癌术后组织病理学和生化复发,可能为术后随访和治疗策略提供决策支持。

研究设计与样本

  • 多中心回顾性研究,纳入四个中心2015年1月至2023年3月间666例前列腺癌患者(发现队列545例,测试队列121例),基于治疗前双参数MRI及临床病理数据建模。

诊断标准与关键数值

  • 测试队列中pred-BCR、pred-ECE、pred-PLNM、pred-GG模型的AUC分别为0.841、0.764、0.896、0.698。
  • 测试队列中联合模型M3的AUC为0.884,M2为0.863,M1为0.838(95%CI 0.750-0.925)。
  • DeLong检验显示M3显著高于M1(p=0.028)和M2(p=0.044)。

临床应用与阅片要点

  • 联合模型M3不依赖病理活检结果,可用于术前无创预测术后组织病理学与生化复发风险。
  • pred-PLNM模型AUC为0.896、pred-ECE为0.764,可为术前评估盆腔淋巴结转移和包膜外侵犯提供参考。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To develop and evaluate the performance of a noninvasive radiomics combined model based on preoperative bi-parametric MRI to assess biochemical recurrence (BCR) risk factors and to predict biochemical recurrence free survival in PCa patients.

MATERIALS AND METHODS: Pretreatment bp-MRI and clinicopathology data of 666 (discovery cohort, 545; test cohort, 121) PCa patients from four centers between January 2015 to March 2023 were retrospectively included. To predict BCR, extracapsular extension (ECE), pelvic lymph node metastasis (PLNM), and Gleason Grade group (GG), the pred-BCR, pred-ECE, pred-PLNM, and pred-GG models were developed, respectively. Subsequently, a logistic regression algorithm was used to combine one or more radiomics models and clinicopathology variables into radiomics-clinicopathology combined models (M1, M2) and radiomics-clinical combined model without pathology results (M3) for predicting BCR.

RESULTS: In the test cohort, the AUCs for the pred-BCR, pred-ECE, pred-PLNM, and pred-GG models were 0.841, 0.764, 0.896, and 0.698. Of the three combined models, M3 has the best prediction performance with an AUC of 0.884, M2 is the following with an AUC of 0.863, and M1 has the lowest performance with an AUC of 0.838 (95% CI 0.750-0.925) in the test cohort. Delong's test showed that the M3 was significantly higher (M1 vs. M3, p = 0.028; M2 vs. M3, p = 0.044).

CONCLUSION: The combined model developed in this study, which is not dependent on pathologic biopsies, can noninvasively predict postoperative histopathology and BCR after PCa, therefore may provide decision support for follow-up and treatment strategies for patients in the postoperative period.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Wu SY, Wang Y, Fan P, et al. Bi-parametric MRI-based quantification radiomics model for the noninvasive prediction of histopathology and biochemical recurrence after prostate cancer surgery: a multicenter study. Abdom Radiol (NY). 2025. PMID: 40095016. doi:10.1007/s00261-025-04873-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。